Demetrios Tzimas
Stony Brook University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Demetrios Tzimas.
Endoscopy | 2017
Dennis Yang; Jose Nieto; Ali Siddiqui; Brian P. Riff; Christopher J. DiMaio; Satish Nagula; Amr Ismail; Saowanee Ngamreungphong; Mouen A. Khashab; Mihir S. Wagh; Demetrios Tzimas; Jonathan M. Buscaglia; Daniel S. Strand; Andrew Y. Wang; Shailendra S. Chauhan; Chris E. Forsmark; Peter V. Draganov
Background and study aim Use of the fully covered self-expandable metal stent (SEMS) for benign luminal gastrointestinal (GI) stricture (BLGS) has been limited by the migration rate. The role of the lumen-apposing metal stent (LAMS) for BLGS is not well defined. We assessed the safety, feasibility, and efficacy of LAMS for the treatment of BLGS. Patients and methods This was an observational, open-label, retrospective, single-arm, multicenter consecutive case series of patients undergoing LAMS placement for BLGS. Technical success was defined as successful placement of the LAMS. Short- and long-term clinical success rates were defined as symptom improvement/resolution with indwelling stent and after stent removal, respectively. All adverse events and additional interventions were recorded. Results A total of 30 patients (mean age 51.6 years; 63.3 % women) underwent LAMS placement for GI strictures (83.9 % anastomotic). Median stricture diameter and length were 4.5 mm (range 2 - 10 mm) and 8 mm (range 5 - 10 mm), respectively. Technical success was achieved in 29 patients (96.7 %), with an adverse event rate of 13.3 %. The stent migration rate was 8.0 % (2/25) on follow-up endoscopy. Short-term clinical success was achieved in 90.0 % (27/30) at a median of 60 days (interquartile range [IQR] 40 - 90 days). Most patients (19/23; 82.6 %) experienced sustained symptom improvement/resolution without the need for additional interventions at a median follow-up of 100 days (IQR 60 - 139 days) after LAMS removal. Conclusion This multicenter study demonstrated that LAMS placement represents a safe, feasible, and effective therapeutic option for patients with BLGS and is associated with a low stent migration rate. Our initial findings suggest that future prospective comparative studies are needed on the use of LAMS, endoscopic dilation, and conventional SEMS. .
Clinical Gastroenterology and Hepatology | 2017
Olaya I. Brewer Gutierrez; Noor Bekkali; Isaac Raijman; Richard Sturgess; Divyesh V. Sejpal; Hanaa Dakour Aridi; Stuart Sherman; Raj J. Shah; Richard S. Kwon; James Buxbaum; C. Zulli; Wahid Wassef; Douglas G. Adler; Vladimir M. Kushnir; Andrew Y. Wang; Kumar Krishnan; Vivek Kaul; Demetrios Tzimas; Christopher J. DiMaio; Sammy Ho; Bret T. Petersen; Jong Ho Moon; B. Joseph Elmunzer; George Webster; Yen I. Chen; Laura K. Dwyer; Summant Inamdar; Vanessa Patrick; Augustin Attwell; Amy Hosmer
BACKGROUND & AIMS: It is not clear whether digital single‐operator cholangioscopy (D‐SOC) with electrohydraulic and laser lithotripsy is effective in removal of difficult biliary stones. We investigated the safety and efficacy of D‐SOC with electrohydraulic and laser lithotripsy in an international, multicenter study of patients with difficult biliary stones. METHODS: We performed a retrospective analysis of 407 patients (60.4% female; mean age, 64.2 years) who underwent D‐SOC for difficult biliary stones at 22 tertiary centers in the United States, United Kingdom, or Korea from February 2015 through December 2016; 306 patients underwent electrohydraulic lithotripsy and 101 (24.8%) underwent laser lithotripsy. Univariate and multivariable analyses were performed to identify factors associated with technical failure and the need for more than 1 D‐SOC electrohydraulic or laser lithotripsy session to clear the bile duct. RESULTS: The mean procedure time was longer in the electrohydraulic lithotripsy group (73.9 minutes) than in the laser lithotripsy group (49.9 minutes; P < .001). Ducts were completely cleared (technical success) in 97.3% of patients (96.7% of patients with electrohydraulic lithotripsy vs 99% patients with laser lithotripsy; P = .31). Ducts were cleared in a single session in 77.4% of patients (74.5% by electrohydraulic lithotripsy and 86.1% by laser lithotripsy; P = .20). Electrohydraulic or laser lithotripsy failed in 11 patients (2.7%); 8 patients were treated by surgery. Adverse events occurred in 3.7% patients and the stone was incompletely removed from 6.6% of patients. On multivariable analysis, difficult anatomy or cannulation (duodenal diverticula or altered anatomy) correlated with technical failure (odds ratio, 5.18; 95% confidence interval, 1.26–21.2; P = .02). Procedure time increased odds of more than 1 session of D‐SOC electrohydraulic or laser lithotripsy (odds ratio, 1.02; 95% confidence interval, 1.01–1.03; P < .001). CONCLUSIONS: In a multicenter, international, retrospective analysis, we found D‐SOC with electrohydraulic or laser lithotripsy to be effective and safe in more than 95% of patients with difficult biliary stones. Fewer than 5% of patients require additional treatment with surgery and/or extracorporeal shockwave lithotripsy to clear the duct.
Gastrointestinal Endoscopy | 2017
Ali M. Abbas; Andrew T. Strong; David L. Diehl; Brian C. Brauer; Iris H. Lee; Rebecca Burbridge; Jaroslav Zivny; Jennifer T. Higa; Marcelo Falcão; Ihab I. El Hajj; Paul R. Tarnasky; Brintha K. Enestvedt; Alexander R. Ende; Adarsh M. Thaker; Rishi Pawa; Priya A. Jamidar; Kartik Sampath; Eduardo Guimarães Hourneaux de Moura; Richard S. Kwon; Alejandro L. Suarez; Murad Aburajab; Andrew Y. Wang; Mohammad H. Shakhatreh; Vivek Kaul; Lorna Kang; Thomas E. Kowalski; Rahul Pannala; Jeffrey L. Tokar; A. Aziz Aadam; Demetrios Tzimas
BACKGROUND AND AIMS The obesity epidemic has led to increased use of Roux-en-Y gastric bypass (RYGB). These patients have an increased incidence of pancreaticobiliary diseases, yet standard ERCP is not possible because of surgically altered gastroduodenal anatomy. Laparoscopy-assisted ERCP (LA-ERCP) has been proposed as an option, but supporting data are derived from single-center small case series. Therefore, we conducted a large multicenter study to evaluate the feasibility, safety, and outcomes of LA-ERCP. METHODS This is a retrospective cohort study of adult patients with RYGB who underwent LA-ERCP in 34 centers. Data on demographics, indications, procedure success, and adverse events were collected. Procedure success was defined when all the following were achieved: reaching the papilla, cannulating the desired duct, and providing endoscopic therapy as clinically indicated. RESULTS A total of 579 patients (median age, 51; 84% women) were included. Indication for LA-ERCP was biliary in 89%, pancreatic in 8%, and both in 3%. Procedure success was achieved in 98%. Median total procedure time was 152 minutes (interquartile range [IQR], 109-210), with a median ERCP time of 40 minutes (IQR, 28-56). Median hospital stay was 2 days (IQR, 1-3). Adverse events were 18% (laparoscopy related, 10%; ERCP related, 7%; both, 1%) with the clear majority (92%) classified as mild/moderate, whereas 8% were severe and 1 death occurred. CONCLUSIONS Our large multicenter study indicates that LA-ERCP in patients with RYGB is feasible with a high procedure success rate comparable with that of standard ERCP in patients with normal anatomy. The ERCP-related adverse events rate is comparable with conventional ERCP, but the overall adverse event rate was higher because of the added laparoscopy-related events.
Gastrointestinal Endoscopy | 2017
Hervé Tiriac; Juan Carlos Bucobo; Demetrios Tzimas; Suman Grewel; Joseph F. LaComb; Leahana Rowehl; Satish Nagula; Maoxin Wu; Joseph Kim; Aaron R. Sasson; Shivakumar Vignesh; Laura Martello; Maria Munoz-Sagastibelza; Jonathan Somma; David A. Tuveson; Ellen Li; Jonathan M. Buscaglia
Archive | 2018
Maria Munoz-Sagastibelza; Hervé Tiriac; Shivakumar Vignesh; J. P. Sanchez; Jonathan Somma; Ellen Li; Juan Carlos Bucobo; Demetrios Tzimas; Maoxin Wu; L. Martello-Rooney; David A. Tuveson; Jonathan M. Buscaglia
Gastrointestinal Endoscopy | 2018
Sachin Wani; Matthew Hall; Samuel Han; Eva Aagaard; Violette C. Simon; Linda Carlin; Swan Ellert; Wasif M. Abidi; Todd H. Baron; Brian C. Brauer; Hemant Chatrath; Gregory A. Cote; Koushik K. Das; Christopher J. DiMaio; Steven A. Edmundowicz; Ihab I. El Hajj; Hazem T. Hammad; Sujai Jalaj; Michael L. Kochman; Sri Komanduri; Linda S. Lee; V. Raman Muthusamy; Andrew S. Nett; Mojtaba Olyaee; Kavous Pakseresht; Pranith Perera; Patrick R. Pfau; Cyrus Piraka; Amit Rastogi; Raj J. Shah
Gastroenterology | 2018
Sachin Wani; Samuel Han; Eva Aagaard; Matthew Hall; Violette C. Simon; Wasif M. Abidi; Subhas Banerjee; Todd H. Baron; Michael J. Bartel; Erik Bowman; Brian C. Brauer; Jonathan M. Buscaglia; Linda Carlin; Amitabh Chak; Hemant Chatrath; Abhishek Choudhary; Bradley Confer; Gregory A. Cote; Koushik K. Das; Christopher J. DiMaio; Andrew M. Dries; Steven A. Edmundowicz; Abdul Hamid El Chafic; Ihab I. El Hajj; Swan Ellert; Jason Ferreira; Anthony Gamboa; Ian S. Gan; Lisa M. Gangarosa; Bhargava Gannavarapu
Clinical Gastroenterology and Hepatology | 2018
Arslan Talat; Demetrios Tzimas; Juan Carlos Bucobo
Gastrointestinal Endoscopy | 2017
Olaya I. Brewer Gutierrez; Saowonee Ngamruengphong; Isaac Raijman; Richard Sturgess; Divyesh V. Sejpal; Stuart Sherman; Raj J. Shah; Richard S. Kwon; James Buxbaum; Claudio Zulli; Wahid Wassef; Douglas G. Adler; Andrew Y. Wang; Kumar Krishnan; Vivek Kaul; Demetrios Tzimas; Christopher J. DiMaio; Sammy Ho; Bret T. Petersen; George Webster; Moon Sung Lee; Yen-I. Chen; Laura k. Dwyer; Sumant Inamdar; Sheryl Lynch; Augustin Attwell; Amy Hosmer; Amar Manvar; Christopher Ko; Attilio Maurano
Gastrointestinal Endoscopy | 2016
Demetrios Tzimas; Juan Carlos Bucobo; Jonathan M. Buscaglia; Purvi Parikh; Aaron R. Sasson; Rebecca A. Nelson; Mark A. Talamini; Joseph Kim